Immunoactinopathies revisited: understanding clinical manifestations and biological pathways
Open Access
- 5 June 2025
- journal article
- Published by American Society of Hematology in Blood
- Vol. 145 (23) , 2709-2732
Abstract
Immune cell functionality is highly dependent on the actin cytoskeleton. The actin cytoskeleton is regulated by a complex molecular machinery that involves multiple genes. Mutations in these genes can cause inborn errors of immunity, also termed immunoactinopathies, of which Wiskott-Aldrich syndrome is the best-characterized entity. Currently, mutations in 23 genes can be considered causative of immunoactinopathies. Immunoactinopathies are rare disease entities with complex combinations of clinical manifestations, including immunodeficiency, immune dysregulation, malignancies, atopy, thrombocytopenia and bleeding, skin involvement, or congenital defects. Prompt diagnosis is crucial, because hematopoietic stem cell transplantation in an early phase can offer cure and prevent further complications. This review provides a detailed summary of the clinical experience with immunoactinopathies so far, elaborates on the most distinguishing features of immunoactinopathies by providing a clinical categorization, and links this information to the underlying biological pathways. This information may be of help to clinicians in the diagnosis of patients and to eventually improve patient care.Keywords
This publication has 220 references indexed in Scilit:
- Ending a diagnostic odyssey—The first case of Takenouchi–Kosaki syndrome in an African patientClinical Case Reports, 2021
- Aplasia cutis congenita in a CDC42‐related developmental phenotypeAmerican Journal of Medical Genetics Part A, 2020
- Progressive macrothrombocytopenia and hearing loss in a large family with DIAPH1 related diseaseAmerican Journal of Medical Genetics Part A, 2017
- Further evidence of a mutation in CDC42 as a cause of a recognizable syndromic form of thrombocytopeniaAmerican Journal of Medical Genetics Part A, 2015
- Novel loss‐of‐function variants in DIAPH1 associated with syndromic microcephaly, blindness, and early onset seizuresAmerican Journal of Medical Genetics Part A, 2015
- B‐cell intrinsic TLR7 signals promote depletion of the marginal zone in a murine model of Wiskott–Aldrich syndromeEuropean Journal of Immunology, 2015
- Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: Yet another locus for thrombocytopenia and developmental delayAmerican Journal of Medical Genetics Part A, 2015
- Inhibition of RAS Activation Due to a Homozygous Ezrin Variant in Patients with Profound Intellectual DisabilityHuman Mutation, 2014
- Functional Analysis of a De NovoACTBMutation in a Patient with Atypical Baraitser-Winter SyndromeHuman Mutation, 2013
- Further Characterization of the DFNA1 Audiovestibular PhenotypeJAMA Otolaryngology–Head & Neck Surgery, 1998